DexCom (DXCM) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $91.48 +0.75%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $84.3 million versus the consensus estimate of $79.65 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
